RecruitingNot ApplicableNCT04997473

Behavioral Weight Loss Intervention Utilizing Mobile Health Technology in Hematopoietic Stem Cell Transplant Patients

Sponsor

University of California, Los Angeles

Enrollment

20 participants

Start Date

Aug 15, 2021

Study Type

INTERVENTIONAL

Conditions

Obesity Stem Cell Transplant

Summary

Pilot study enrolling obese post HSCT (hematopoietic stem cell transplantation) patients at the hematology/oncology clinic at the Mattel Children's Hospital, University of California, Los Angeles. Parameters include percent over the 95th percentile (%BMIp95), zBMI, fasting metabolic metrics, addictive eating habits, and motivation for change.

Eligibility

Min Age: 13 YearsMax Age: 30 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a mobile health app-based behavioral weight loss program for young people (ages 13-30) who have had a blood stem cell transplant (HSCT) and developed obesity as a result. The program aims to help them adopt healthier habits using their smartphones. You may be eligible if: - You are between 13 and 30 years old - You have a history of hematopoietic stem cell transplant (HSCT) of any type - It has been at least 100 days since your transplant - Your BMI is at or above the 85th percentile for your age and gender (obesity range) - You can read English (the app is only available in English) You may NOT be eligible if: - You are under 13 or over 30 years old - It has been less than 100 days since your transplant - Your BMI is not in the obese range Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALW8L2G mobile health (mHealth) app

Weight loss phone app based on addiction principles. This intervention has been validated in two prior studies. Participants will also interact with coaches throughout the intervention

Locations(1)

UCLA Mattel Children's Hospital

Los Angeles, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04997473

Related Trials

Safety and Effectiveness of Orbera365™ Intragastric Balloon System

NCT070620945 locations

A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back Pain

NCT0703509340 locations

A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)

NCT0643927773 locations

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

NCT0667254950 locations

A Study of ABBV-295 Subcutaneous Injections to Assess Adverse Events and Pharmacokinetics in Adult Participants With Obesity

NCT072912322 locations